KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Liabilities (2016 - 2025)

Medpace Holdings' Total Liabilities history spans 11 years, with the latest figure at $1.5 billion for Q4 2025.

  • For Q4 2025, Total Liabilities rose 18.9% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, up 18.9%, while the annual FY2025 figure was $1.5 billion, 18.9% up from the prior year.
  • Total Liabilities reached $1.5 billion in Q4 2025 per MEDP's latest filing, up from $1.5 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.5 billion in Q4 2025 to a low of $592.4 million in Q1 2021.
  • Average Total Liabilities over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2022.
  • Peak YoY movement for Total Liabilities: surged 67.07% in 2022, then dropped 1.58% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $707.0 million in 2021, then soared by 36.65% to $966.1 million in 2022, then grew by 13.64% to $1.1 billion in 2023, then grew by 16.16% to $1.3 billion in 2024, then increased by 18.9% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Total Liabilities are $1.5 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.4 billion (Q2 2025).